Abstract
This article describes the characteristics of alloantibodies associated with accelerated in vivo red cell destruction, pretransfusion tests performed to detect these antibodies, and the resolution of the incompatible crossmatch. Current transfusion practices, the indications for, and the complications of red cell transfusions are discussed.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
